| Application no. and date | 17722080.3 (espacenet) (Federated) (European Patent Register), 20170418 | | Patent/reg. no. and date | DK/EP 3445785, 20220622 | | Publication date | 20190227 | | Priority no. and date | FI 20165336, 20160418, FI 20165335, 20160418 | | EP pub. no. and date |
EP 3445785 20190227 | | Effective date | | | Applicant/owner | Faron Pharmaceuticals OY, Joukahaisenkatu 6
20520 Turku, FI | | Applicant ref. no. | P80636DK01 | | Inventor | Jalkanen, Markku, Rauvolantie 77
20760 Piispanristi, FI,
MAKSIMOW, Mikael, Puhuri 11 G 23
20900 Turku, FI,
VAINIO, Marita, Tossupojankuja 5
20900 Turku, FI | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , A61P 37/04 (2006.01) , C07K 16/28 (2006.01) , G01N 33/50 (2006.01) | | Title | HUMANISEREDE ANTI-CLEVER-1-ANTISTOFFER OG ANVENDELSE DERAF | | Int. application no. | FI2017050285 | | Int. publication no. | WO2017182705 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
